Cholecystokinin (CCK) involvement in depression-like disorders is poorly documented. Here, we investigated whether CCKergic neurotransmission is relevant to depressive-like symptoms and antidepressant therapy using a novel preclinical model based on repeated social defeat over 4 weeks in rats. Repeated social defeat triggers changes that could be considered as behavioral and biological correlates of depressive symptoms in humans, such as a hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis (increase of serum corticosterone levels and of adrenal gland weight), increased immobility time in the forced swimming test (FST), decrease of body weight and of sweet water consumption and reduction of hippocampal volume associated with a decreased cell proliferation in the dentate gyrus. In addition, in vivo microdialysis showed that cortical CCK release was tonically increased in defeated rats. Chronic imipramine treatment (16 mg kg À1 per day for 25 days) prevented both the repeated social defeat-induced alterations of biological and behavioral parameters and the associated increase of cortical CCK release. Chronic blockade of CCK2 receptors by the specific antagonist CI-988 (1 mg kg À1 per day for 25 days) also normalized immobility time in the FST and prevented HPA axis hyperactivity, reduction of hippocampal volume and cell proliferation and decreased sweet water intake normally evoked by repeated social defeat. These data showed that the repeated social-defeat paradigm can be considered as a suitable model of 'depression' in rats. The causal link between social defeat-evoked (1) increase in cortical CCKergic neurotransmission and (2) depression-like symptoms that we highlighted here strongly suggests that CCKergic systems may be a relevant target for novel antidepressant therapy.
Introduction
The validity of an animal model of psychopathological disorders must be assessed with respect to predictive, face and construct validity. 1 Many animal models fail with respect to face or construct validity. To improve our knowledge of the causal mechanisms of stress-related disorders, natural animal models allowing an experimental analysis of the etiology and temporal dynamics of these diseases are required. For this purpose, the social-defeat procedure seems to be an appropriate model. 2 Acute or brief intermittent social-defeat stress allowed the analysis of behavioral, endocrine, circadian disturbances and of brain system alterations which were prevented by anxiolytic treatments. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] However, when applied for a long time, the social-defeat procedure, chiefly in mice, was shown to be responsive to antidepressant treatments, [13] [14] [15] [16] whereas acute or chronic anxiolytic treatment effects are still a matter of discussion. 17, 18 It is not easy to define the difference between anxiety and depression since chronic administration of antidepressants may have anxiolytic effects and anxiety and depression syndromes share several overlapping symptoms. 17, 19 However, modeling transitions from anxiety to depression require to use prolonged social stressors, that is, for at least 20 days. 2, 13, 14, 17 Cholecystokinin (CCK) systems are widely distributed in brain with particularly high concentrations of the peptide in cortical regions. 20, 21 Cortical CCK systems, through CCK2 rather than CCK1 receptors, play a role in stress-and/or anxiety-related behaviors. 22 Increases of CCK levels, CCK receptor density and CCK release have been reported in cerebral cortex of rats subjected to stressful or anxiogenic-like conditions. 11, 22, 23 Bradwejn and collaborators have shown alterations of CCK2 receptor-mediated mechanisms in the pathophysiology of panic disorder. 24 However, only a few data have raised the hypothesis that central CCK-containing neurons may also participate in the neurobiological mechanisms of depression. 22 In animals, the involvement of CCK in depression-like disorders has been assessed in only few studies, [25] [26] [27] ending with the conclusion that CCK-2 receptor blockade might exert antidepressantlike effects. 28 In humans, conflicting results have been reported about CCK levels in the cerebrospinal fluid (CSF), CCK receptor density and behavioral responses to CCK receptor ligands in patients diagnosed with depression 22, 29 and, to our knowledge, the potential antidepressant properties of CCK-2 receptor antagonists have not yet been investigated.
These considerations led us to investigate whether or not CCKergic neurotransmission may be relevant to depressive-like symptoms and antidepressant therapy. To this end, 1 . we set up a rat model of depression based on repeated social defeat extended over 4 weeks. Validation of this paradigm was based on: (1) the occurrence of depression-like symptoms, such as anhedonia, body weight alteration, hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis, decreased hippocampal cell proliferation and (2) the efficacy of a chronic treatment with the antidepressant drug, imipramine to reverse to these symptoms; 2. we assessed whether CCK systems were altered in rats subjected to this paradigm, by measuring CCK release in microdialysis experiments. Probes were inserted in frontal cortex that plays an important role in depression. 30 In addition, the causal link between altered CCKergic neurotransmission and depression-like symptoms was investigated by examining whether a chronic treatment with the CCK2 receptor antagonist, CI-988, 31 could alleviate these symptoms in defeated rats.
Materials and methods

Animals
Male Sprague-Dawley (SD) rats (Centre d'Elevage R Janvier, 53940 Le Genest-St-Isle, France), weighing 300-325 g (8 weeks old) on their arrival in the laboratory, served as experimental intruder or control animals. They were housed in individual cages (l: 45 cm; w: 25 cm; h: 17 cm) for 10 days before the beginning of the experiments, in a chronobiologic animal facility (Enceinte Autonome d'Animalerie, A110SP, Thermo Electron Corporation, Saint Herblain, France). The chronobiologic facility was equipped with equispaced, soundproof, temperature-controlled (21.071.0 1C) compartments provided with filtered air. Each compartment had its own light-dark cycle control. Long Evans (LE) rats (Centre d'Elevage R Janvier), weighing 700-800 g, served as resident rats in confrontation encounters. At their arrival in the laboratory, they were housed in appropriate cages (l: 45 cm; w: 45 cm; h: 17 cm) together with a ligatured female for 1 month. Then, the residents were chosen for their reliable aggressive behavior as assessed during confrontations with intruders. During the social-defeat procedure, the females were removed from the cages. The same 10 LE rats were used for all the successive series of experiments. All animals were kept under controlled environmental conditions (2271 1C, 60% relative humidity, 12/12 h light-dark cycle with lights on at 0700, food and water ad libitum). Procedures involving animals and their care were carried out in conformity with the institutional guidelines, which are in compliance with national and international laws and policies (Council directive no. 87-848, 19 October 1987, Ministère de l'Agriculture et de la Forêt, Service Vétérinaire de la Santé et de la Protection Animale, permissions no. 75-116 to MH, no. 75-1178 to JJB).
Experimental procedures
Social-defeat procedure. The behavioral procedure consisted of conditioning sessions with the same pairs of residents and intruders. The 45-min conditioning sessions started at 1000. They were divided into two consecutive periods. During period I (30-min), intruders were placed alone in a protective cage without cover (l: 25 cm; w: 25 cm; h: 30 cm) inside the resident home cage. The resident home cage had no cover and was surrounded by a 100 cm high wire-mesh enclosure (l: 45 cm; w: 45 cm). The protective cage allowed unrestricted visual, auditory and olfactory interactions with the resident but precluded close physical contact. During period II (15-min), the protective cage was removed (defeated intruders) allowing physical confrontation. Generally, intruders were attacked within 30 s, and three to four confrontations of E10 s each occurred, during which the intruding animal was always dominated by the resident rat and adopted submissive posture, that is, when the defeated rat was on its back under the resident rat for approximately 5 s. The total duration of encounters was E1 min for the whole 15 min period II. During physical confrontations, intruders were exceptionally wounded and only at skin-deep level in such cases (in less than 5% of confrontation sessions). Nondefeated intruders were subjected to the same procedure, but without the resident rat for the whole 15 min period II. Therefore, they were never physically attacked and defeated by the resident. The 45-min conditioning session was repeated once daily for 4 days on week 1. During weeks 2 and 3, intruders were subjected to the socialdefeat procedure once daily for 2 days, and on week 4, the procedure was repeated again once daily for 4 days (Figure 1 ). One group of animals was intended for behavioral and physiological analyses and another group for microdialysis experiments. For the latter, after the last conditioning session, that is, 25 days after the first session, intruders were implanted with a guide cannula, and 4 days later, with the microdialysis probe (see below) ( Figure 1) .
In separate experiments, control rats were kept in their home cage during 40 days.
Body weight. Body weights of defeated and nondefeated rats, treated or not with imipramine or CI-988, were measured daily at 0900, before (7 days), during (25 days) and after (4 days) the social-defeat procedure ( Figure 1 ).
Adrenal gland weight. 5 days after the last conditioning session, defeated and nondefeated intruders, treated or not with imipramine or CI-988, were decapitated and adrenals were removed, dissected free of adhering fat and weighed (Figure 1 ). Organ weights are expressed relative to body weights (mg gland per 100 g body weight).
Sweet water consumption. From 1 week before the beginning of the conditioning sessions (D7 to D1) until 5 days after the last conditioning session, two bottles (one filled with water and the other one containing 1.5% sucrose 32 ) were continuously available to rats (Figure 1 ). Sucrose and water intakes were measured daily at 0900. Bottles were switched every day from left to right side of the cage throughout the experiment in order to avoid any place preference. Sweet water consumption was calculated as a percentage of control values (D7 to D1) measured for 2 days in each group.
Food consumption. Food intake was measured daily at 0900, before (7 days), during (25 days) and after (5 days) the social-defeat procedure (Figure 1 ). Data are expressed as the sum of daily food intakes measured in each animal group during each week.
Forced swimming test. An adapted version of the forced swimming test (FST) originally described by Porsolt et al. 33 was used. Experiments were performed between 0930 and 1300. 5 days after the last conditioning session, SD rats were individually placed into glass cylinders (40 cm height; 20 cm diameter) containing 29 cm of water at 30711C. After 8 min, they were transferred to a 301C drying environment for 15 min. The water was changed after each animal's session and the cylinder cleaned to avoid the influence of alarm pheromones left behind by the previous animal. The immobility time was measured with a stopwatch. A rat was considered immobile when floating and making only the necessary movements to keep its nostrils above the water surface. A trained experimenter blind to the treatment made animal observation and measurements. Both room and water temperatures were monitored at the end of each session. Each rat was individually subjected to only one swimming session. 34 Cell proliferation and hippocampal volume BrdU labeling. On day 29, rats received two injections of bromodeoxyuridine (BrdU) (75 mg kg i.p. of chloral hydrate. Transcardiac perfusion with saline was carried out to clear the blood, followed by 4% cold paraformaldehyde (PFA) in phosphatebuffered saline (PBS). After perfusion, brains were postfixed overnight in 4% PFA/PBS at 41C. The day after, serial sections (40-mm thickness) were cut through the entire hippocampus plates 26-40 35 ) on a freezing microtome, and sections were stored overnight in PBS at 41C.
Immunohistochemistry. The next day, free-floating sections were used for the immunohistochemical visualization of BrdU labeling. After several PBS rinses, sections were incubated for 5 min in 3% H 2 O 2 to get rid of endogenous peroxidases. They were then washed in PBS, incubated for 30 min in 2 N HCl followed by 30 min in 0.1 M boric acid. After blocking with 5% horse serum in 0.1% Triton X-100, sections Figure 1 Repeated social-defeat procedure. The experimental procedure consisted of 45-min conditioning sessions (black triangles) with the same pairs of residents and intruders. The 45-min conditioning session was repeated once daily for 4 days on week 1. During weeks 2 and 3, intruders were subjected to the social-defeat procedure once daily for 2 days, and, on week 4, the procedure was repeated again once daily for 4 days. One group of animals was intended for behavioral and physiological analyses and another one for microdialysis experiments. For the latter, after the last conditioning session, that is, 25 days after the first session, intruders were implanted in frontal cortex with a guide cannula, and 4 days later, with the microdialysis probe. Chronic treatment with imipramine (16 mg kg À1 per day), the selective CCK2 receptor antagonist CI-988 (1 mg kg À1 per day) or saline started the day after the last conditioning session of week 1 (day 5) and lasted until the day of microdialysis experiments, forced swimming test or killing for HPA axis activity assessment, cell proliferation quantification, volumetric analysis of the hippocampus (day 30).
were incubated with mouse anti-BrdU antibodies (1:500; Dakocytomation, Trappes, France) overnight at 41C, then for 2 h with a secondary antibody (1:400; biotinylated horse anti-mouse; Biovalley, Marnela-Vallée, France). After amplification with an avidin-biotin complex (Biovalley), sections were exposed to diaminobenzidine (Sigma), washed with PBS and mounted onto microscope slides (Superfrost Plus). Slices were finally processed for counterstaining with cresyl violet and coverslipped. All slides were coded prior to analysis.
For triple immunolabeling (differentiation), sections were simultaneously incubated overnight at 41C with rat anti-BrdU antibodies (1:100; Abcys, Paris, France), mouse anti-NeuN antibodies (1:500; Dakocytomation), rabbit anti-GFAP antibodies (1:300; Dakocytomation). After washing, sections were incubated for 2 h with biotinylated anti-rat IgG (Biovalley), then for a further 2 h with secondary anti-mouse CY5 (Invitrogen, Cergy Pontoise, France), secondary anti-rabbit Alexa Fluor 568 (Invitrogen) and streptavidin Alexa Fluor 488 (Invitrogen). After washing, slices were mounted onto microscope slides (Superfrost Plus) and finally coverslipped.
Quantification of BrdU labeling. Every sixth section throughout the whole hippocampus was processed for the quantification of BrdU immunohistochemical labeling. Using this spacing ensures that the same neuron is not counted in two sections. All BrdUlabeled cells in the dentate gyrus (granule cell layer, GCL) and hilus were counted in each section by an experimenter blind to the slide code. To distinguish single cells within clusters, all counts were performed at Â 400 and Â 1000 under a light microscope (Leica DMRD). A cell was counted as being in the subgranular zone (SGZ) of the dentate gyrus if within or touching the SGZ. Cells that were located at a distance corresponding to more than two cells away from the SGZ were classified as hilar cells. The total number of BrdU-labeled cells per section was determined and multiplied by 6 to obtain the total number of cells per dentate gyrus (see 36 ). Phenotypic analysis of fluorescently labeled BrdU cells was performed using a confocal microscope (Leica Microsystems, Heidelberg GmbH, Germany). Cells were scanned and optically sectioned in the Z plane.
For the volumetric analysis of GCL, the layer was carefully demarcated on both right and left sides in each section and its area was calculated using Lucia GF version 4.71. The delimited areas were summed for each animal and multiplied by 240 mm (that is, thickness of the slice plus distance between serial sections) to obtain an estimate of GCL total volume. 37 Microdialysis After 24 h of the last conditioning session, intruders were anesthetized with chloral hydrate (375 mg kg À1 , i.p.). A stainless-steel guide cannula (CMA/12, CMA Microdialysis, North Chelmsford, MA, USA; outer diameter 0.7 mm) was placed at coordinates allowing the tip to be just above the frontal cortex: anteroposterior, þ 2.7 mm from bregma; lateral, À1.7 mm from bregma; horizontal, À0.8 mm from the skull. 35 The cannula was then secured to the skull with dental cement, and the skin was sutured. Animals were kept in individual cages for 4 days before the microdialysis experiment.
The day before the experiment, the rats were placed in a Plexiglas microdialysis bowl (35 cm in diameter) with free access to food and water. The next morning, a microdialysis probe (CMA/12, CMA Microdialysis; cutoff: 20 000 Da; outer diameter 0.5 mm; 2 mm in length) was introduced into the guide cannula so as to protrude by 2 mm into the Fr2 area of frontal cortex. 23 In rats, the Fr2 region is considered as an area of the prefrontal cortex. 38 The probe was continuously perfused at a flow rate of 3.0 ml min À1 with an artificial CSF (aCSF). 11, 23, 32 To allow dialysis to reach steady state around the probe membrane, perfusion was performed for 90 min (washout period) before collection of the first fraction. 23 Then, 11 fractions of 90 ml (each corresponding to 30 min of perfusion) were collected at 01C and immediately frozen at À301C until determination of their CCK-like material (CCKLM) contents with a sensitive radioimmunoassay (RIA).
The in vitro recovery of CCKLM was estimated as described previously. 11, 23, 32 Briefly, the microdialysis probes were immersed in a solution containing a known concentration of exogenous CCK and recovery was calculated as the percentage of CCKLM quantified in the microdialysates over that present in the original solution. This percentage was 8.170.2% (mean7s.e.m., n = 16).
During the microdialysis procedure, 2 min before the beginning of the collection of the eighth fraction, intruders (either defeated or nondefeated) were subjected to the period I of the social-defeat procedure (see above). Each rat was gently moved to the protective cage placed inside the usual resident home cage for the 30-min period I and then back to the microdialysis bowl. This was done without having to detach the swivel arm. Thus, during the microdialysis procedure, intruders were threatened, but not defeated by the resident.
Correct placement of microdialysis probes was verified by histological examination. Thus, at the end of the experiment, rats were deeply anesthetized with chloral hydrate (375 mg kg À1 , i.p.), and killed by decapitation. Brains were removed, rapidly frozen in isopentane and stored at À20 1C. They were sectioned in a cryostat and stained with cresyl violet for verification of probe location. When a probe was incorrectly placed, corresponding results were discarded. In this study, no rat was discarded.
Drugs and treatments Imipramine (16 mg kg
À1 per day (ICN, Aurora, OH, USA) 39 ) was used as typical tricyclic antidepressant drug. For the blockade of CCK2 receptors, we used CI-988 (1 mg kg À1 per day; a dose not affecting motor/ exploratory activity 40, 41 ). Despite its limited bioavailability and blood-brain barrier permeability, CI-988 is effective to antagonize CCK2 receptors in vivo, since it exhibits a nanomolar affinity and high selectivity for the CCK2 receptor subtype. 31 Treatment with imipramine, CI-988 or saline started the day after the last conditioning session of week 1 (day 5) and lasted until the day of microdialysis experiment or killing for HPA axis activity determination, cell proliferation quantification or volumetric analysis of the hippocampus (day 30) (Figure 1 ). Imipramine and CI-988 were dissolved in distilled water and saline, respectively, to fill ALZET minipumps (ALZT2ML4, Charles River Laboratories, L'Arbresle, France). Imipramine-, CI-988-or saline-pumps were implanted subcutaneously on the back of intruder rats under light anesthesia with halothane.
Radioimmunoassays
Corticosterone. At the time of killing (at midday), 5 days, 15 days or 1 month after the last conditioning session, blood from trunk vessels was collected in chilled tubes and corticosterone was quantified by RIAs (ICN Biomedicals, Orsay, France) using [ 125 I]corticosterone as radiotracer (see André et al 32 ). Rats were decapitated in a quiet separate room, one after the other, and the place was cleaned after each rat. ; CISBio International, Gif-sur-Yvette, France) and charcoal suspension was 50 mM barbital-HCl, pH 8.5, containing 1 g l À1 sodium azide and 10 mM MgCl 2 . The anti-CCK-8 antiserum was obtained in a rabbit injected repeatedly with CCK-8 coupled to thyroglobulin by glutaraldehyde. 42 For the measurement of CCKLM in microdialysates, 90 ml fractions were mixed with 100 ml of anti-CCK antiserum dilution (in barbital-HCl buffer containing 3.75 g l À1 bovine serum albumin (BSA); 1/1 500 000 final dilution 42 ) and 50 ml barbital-HCl buffer. After a 48 h incubation at 4 1C, 50 ml of the [ , respectively, in the barbital-HCl buffer containing 10% horse serum; 1 ml of the suspension per tube). The tubes were immediately centrifuged at 6000 g for 10 min at 4 1C, and the radioactivity in supernatants was estimated by g-spectrometry.
Standard curves were prepared from RIAs of 0.5-50 pg per tube of authentic sulfated CCK-8 (CCK-8S) in 50 ml of barbital-HCl buffer supplemented with BSA. These aliquots were mixed with 90 ml of aCSF and 100 ml of the antiserum dilution and assayed as described above. The detection limit of the assay was 0.75 pg of CCK-8S per tube, and half displacement of [ Under these RIA conditions, cross reactivity was 233% with nonsulfated CCK-8, 204% with gastrin, 31% with CCK-7S, 26% with nonsulfated CCK-7, 25% with CCK-5, 11% with CCK-33, 1% with CCK-4 and was undetectable with rat calcitonin gene-related peptide (a-CGRP) (up to 2.5 mg per tube), as compared with 100% for synthetic CCK-8S.
The CCKLM content of each fraction was expressed as CCK equivalents, that is, the amount of authentic CCK-8S producing the same displacement of [
125 I]gastrin bound to anti-CCK antibodies as the endogenous material. Values were not corrected for probe recovery calculated from in vitro experiments with authentic CCK-8S.
Statistical analyses
Physiological and behavioral data. Differences in adrenal gland weight, corticosterone levels, hippocampal cell proliferation and immobility time (FST) were validated using two-factorial (repeated social defeat vs treatment) analysis of variance (ANOVA). Body weight, sweet water consumption and food intake were analyzed with a two-way (repeated social defeat vs treatment Â time) ANOVA for repeated measurements. Significance of differences was assessed with Bonferroni test.
Neurochemical data. CCKLM levels (in pg per fraction) in defeated or nondefeated rats, treated or not with imipramine, were analyzed using ANOVA followed by appropriate pairwise comparisons of interest using Bonferroni test. CCKLM levels in dialysate samples collected immediately after the 30-min of period I were compared to basal levels using the two-tailed, paired Student's t-test.
Results
Effects of repeated social defeat on physiological parameters
Body weight. All rats, defeated and nondefeated, had similar body weights before the beginning of the social-defeat procedure (D7 to D1). Changes in body weight as a result of repeated social defeat are shown in Figure 2 . In animals implanted with saline pumps, body weight was lower in defeated-compared to nondefeated intruders. This divergence began after the first conditioning session (D1) and persisted until the end of the experiment (day 29, 506711 g vs 553710 g, P < 0.005). While chronic treatment with CI-988 did not significantly modify the respective gain of body weight in nondefeated (final weight 567715 g) or defeated animals (final weight 49077 g), chronic treatment with imipramine caused a significant reduction of body weight in both defeated (final weight 46875 g) and nondefeated rats (final weight 51077 g) (Figure 2) .
The body weights of animals consuming sweet water were not significantly different from those measured in animals drinking only plain water (data not shown). Results of statistical analyses using twoway ANOVA for repeated measures are shown in Table 1a . On day 29, one-way ANOVA followed by appropriate pairwise comparisons revealed significant differences between saline-defeated and -nondefeated animals (P < 0.005), between saline-defeated animals and imipramine-defeated rats (P < 0.01), between CI-988-defeated animals and CI-988-nondefeated rats (P < 0.005) and between saline-nondefeated animals and imipramine-nondefeated rats (P < 0.005). In contrast, body weights did not significantly differ in saline-defeated rats compared to imipraminenondefeated animals, in saline-defeated rats compared to CI-988-defeated animals and in salinenondefeated rats compared to CI-988-nondefeated animals.
Sweet water consumption. During the 7 days preceding the conditioning sessions, rats drank significantly more sweet water (E30 ml per day) than plain water (E15 ml per day) showing a preference for the sweet water. In saline-nondefeated rats, daily intake remained stable until the end of the experiment. By contrast, in saline-defeated animals, from the first physical confrontation onward, sweet water consumption decreased markedly (E17 ml per day), while plain water intake was unchanged (E15 ml per day). Thus, during the whole experiment, sweet water consumption in defeated rats averaged E60% of that measured in nondefeated animals. During the first week following imipramine pump implantation, sucrose intake decreased in both imipramine-treated nondefeated and defeated intruders (Figure 3) . During the second week of treatment, sucrose intake in these two groups was similar to that in saline-defeated animals. Then, during the last week, sucrose intake markedly increased in the two imipramine-treated groups. In nondefeated rats, the time course of sucrose intake was similar in rats receiving or not CI-988. However, in defeated rats, chronic treatment with CI-988 markedly increased sucrose intake during the last week of the experiment (Figure 3) .
Results of statistical analyses using two-way ANOVA for repeated measures are shown in Table  1a . On day 30, one-way ANOVA followed by appropriate pairwise comparisons revealed a significant difference between saline-defeated and saline-nondefeated animals (P < 0.0001), but no difference between saline-nondefeated rats compared to imipramine-or CI-988-defeated rats and between CI-988-nondefeated rats compared to CI-988-defeated rats.
Food consumption. During the 7 days preceding the conditioning sessions, food intake was E30 g per day in all rats. In saline-nondefeated rats, daily food intake remained stable until the end of the experiment. By contrast, in saline-defeated animals, food consumption markedly decreased (EÀ10 g per day) from the first four physical confrontations (week 1). Then, during the whole experiment, food consumption in saline-defeated rats averaged E23 g per day. During the first week following imipramine pump implantation, food intake decreased in both nondefeated and defeated intruders (Figure 4 ). This effect of imipramine lasted until the end of the experiment. In nondefeated rats, the time course of food intake was similar in rats receiving CI-988 or saline. However, in defeated rats, chronic treatment with CI-988 markedly increased food intake up to values not significantly different from those in CI-988-nondefeated rats the last week of the experiment (week 4) (Figure 4) .
Results of statistical analyses using two-way ANOVA for repeated measures are shown in Table  1a . On week 4, one-way ANOVA followed by appropriate pairwise comparisons revealed a significant difference between saline-defeated and salinenondefeated animals (P < 0.0001), a significant difference between saline-nondefeated rats compared to imipramine-defeated or -nondefeated rats (P < 0.0001), but no difference between saline-nondefeated rats compared to CI-988-defeated rats. weight changes induced by the socialdefeat procedure-effects of imipramine or CI-988 treatment. Body weights of nondefeated and defeated rats receiving, or not, imipramine or CI-988 were measured daily at 0900, before (7 days), during (25 days) and after (4 days) the social-defeat procedure. Imipramine (16 mg kg À1 per day, 25 days) and CI-988 (1 mg kg À1 per day, 25 days) were delivered through ALZET minipumps. Imipramine, CI-988 or saline pumps were implanted subcutaneously on the back of intruders. Each point is the mean7s.e.m. of data obtained for the number of animals indicated on the figure for each group. Social-defeat sessions are marked by black triangles on abscissa. Data on day 29 were analyzed using ANOVA followed by appropriate pairwise comparisons (Bonferroni test) (*P < 0.01, **P < 0.005).
HPA axis. In nondefeated rats, HPA axis activity was not significantly different from that in naive control rats (corticosterone levels 9.7171.42 ng ml
À1
, n = 6; adrenal gland weight 10.6770.31 mg per 100 g, n = 6, compared to values in saline-nondefeated rats; see Table 2 ).
In the saline group, 5 days after the last conditioning session, defeated animals exhibited significant increases in both serum corticosterone levels and adrenal gland weights as compared to nondefeated animals ( Table 2 ). Chronic treatment with imipramine or CI-988 completely prevented the increase in serum corticosterone levels. In addition, imipramine treatment also prevented the increase in adrenal gland weight normally induced by the social-defeat procedure. In contrast, CI-988 treatment was inactive in this respect. Moreover, the latter treatment as well as chronic imipramine affected neither serum corticosterone levels nor adrenal gland weight in nondefeated rats ( Table 2) .
As long-term consequences of the social-defeat procedure, changes in HPA axis activity lasted for at , n = 4; adrenal gland weight: 10.247 0.69 mg per 100 g, n = 4) and then completely disappeared 1 month after the last confrontation (defeated rats: corticosterone levels 12.3672.60 ng ml À1 , n = 6; adrenal gland weight 10.7570.25 mg per 100 g, n = 6, compared to values in saline-nondefeated rats: corticosterone levels 11.5071.77 ng ml À1 , n = 6; adrenal gland weight 10.0770.23 mg per 100 g, n = 6).
Results of statistical analyses using two-way ANOVA for repeated measures are given in Table 1b .
Forced swimming test. 5 days after the last conditioning session (day 30), animals were subjected to FST. Saline-defeated animals spent a significantly longer time immobile than saline-nondefeated rats Figure 3 Time course of sweet water consumption in defeated and nondefeated rats-effects of imipramine or CI-988 treatment. Starting 1 week before the conditioning sessions (D7 to D1) until 5 days after the last conditioning sessions (D25), rats had permanent access to two bottles, one filled with plain water and the other containing 1.5% (w/v) sucrose. Social-defeat sessions are marked by black triangles on abscissa. Results are expressed as percentage of control values (D7 to D1) measured for 2 days in each group. Results on day 30 were analyzed using ANOVA followed by appropriate pairwise comparisons (Bonferroni test) (*P < 0.0001; NS, not significant). Figure 4 Time course of food intake in defeated and nondefeated rats-effects of imipramine or CI-988 treatment. Starting 1 week before the conditioning sessions (D7 to D1) until 5 days after the last conditioning sessions (D25), food intakes were measured daily in nondefeated and defeated rats receiving imipramine, CI-988 or saline. Data are expressed as the sum of daily food intakes measured in each animal group for each week. Results on week 4 were analyzed using ANOVA followed by appropriate pairwise comparisons (Bonferroni test) (*P < 0.0001; NS, not significant). Table 2 Effects of chronic social-defeat procedure on serum corticosterone levels and adrenal gland weight in nondefeated or defeated intruders treated with imipramine, CI-988 or saline
Treatment
Corticosterone (ng ml Defeated and nondefeated rats treated with imipramine, CI-988 or saline were killed 5 days after the last conditioning sessions. Blood from trunk vessels was collected in chilled tubes and corticosterone was quantified by radioimmunoassay. Adrenals were removed, dissected free of adhering fat and weighed. Adrenal gland weights are expressed relative to body weights (mg per 100 g body weight). Serum corticosterone levels and adrenal gland weights in the six different groups were analyzed using ANOVA followed by appropriate pairwise comparisons (Bonferroni test). ***P < 0.002, ****P < 0.0001 compared to saline nondefeated animals.
( Figure 5 ). The immobility time of imipramine-or CI-988-defeated rats did not differ from that of salinenondefeated animals and was significantly shortened compared with that of saline-defeated rats. Results of statistical analyses using two-way ANOVA for repeated measures are shown in Table 1b .
Hippocampal cell proliferation and volume. In saline-defeated intruders, the number of BrdU-labeled cells was significantly reduced, by approximately 25%, as compared to saline nondefeated rats (Figures 6a  and b) . This effect was prevented by chronic imipramine or CI-988 treatment. In imipramine-or CI-988-nondefeated rats, the number of BrdU-labeled cells was not different from that measured in saline nondefeated rats (Figure 6 ). Results of statistical analyses using two-way ANOVA for repeated measures are shown in Table 1b . One-way ANOVA followed by appropriate pairwise comparisons revealed a significant difference between salinedefeated and saline-nondefeated animals (P < 0.02), and a significant difference in saline-defeated rats compared to imipramine-or CI-988-treated defeated animals (P < 0.002, P < 0.005, respectively).
Triple-immunolabeling of hippocampal sections using anti-BrdU, anti-NeuN and anti-GFAP antibodies (Figure 7) showed that the majority of BrdUpositive cells matured into neurons (BrdU þ NeuN: 85%; BrdU þ GFAP: 9%; BrdU only: 6%).
Repeated exposure to social-defeat procedure resulted in a decrease (À10%) of the hippocampal volume in the defeated intruders compared to nondefeated rats (9.3170.30 mm 3 vs 10.4070.02 mm 3 , n = 5, respectively, P < 0.05). In defeated animals Figure 5 Forced swimming test in defeated and nondefeated rats-effects of imipramine or CI-988 treatment. 5 days after the last conditioning session, defeated or nondefeated rats, treated or not, were individually placed into glass cylinders containing 29 cm of water at 30711C. After 8 min, they were transferred to a 301C drying environment for 15 min. Experiments were performed between 0930 and 1300. Each bar is the mean7s.e.m. of immobility duration (in s) for the 8-min test. Results were analyzed using ANOVA followed by appropriate pairwise comparisons (Bonferroni test) (*P < 0.0005 vs saline nondefeated rats; w P < 0.0001 vs imipramine-defeated rats; a P < 0.0005 vs CI-988-defeated rats). Figure 6 Hippocampal cell proliferation in defeated and nondefeated rats-effects of imipramine or CI-988 treatment. On day 29, rats received BrdU injections (2 Â 75 mg kg À1 i.p., 2 h apart) and were killed 24 h later for BrdU immunohistochemical analysis (day 30). Upper panels show representative BrdU-labeled sections from (a) saline-nondefeated, (b) saline-defeated, (c) imipraminedefeated, (d) CI-988-defeated animals. The photomicrograph insert in (a) shows a greater magnification of a group of closely apposed BrdU-positive cells. The majority of BrdU-labeled cells are located in the subgranular zone (SGZ), the area between the granule cell layer (GCL) and the hilus (H) in the hippocampus. BrdU-positive cells were counted in the dentate gyrus and the results are shown as means7s.e.m. in the bottom panel. Results were analyzed using ANOVA followed by appropriate pairwise comparisons (Bonferroni test) (*P < 0.02 vs saline nondefeated rats; w P < 0.002 vs imipramine-defeated rats; a P < 0.005 vs CI-988-defeated rats).
treated with imipramine or CI-988, the hippocampal volumes were similar to those measured in nondefeated animals treated with these compounds (imipramine: 10.0670.59 mm Cortical CCKLM release. In the saline groups, 5 days after the last conditioning session, the spontaneous cortical CCKLM release in defeated intruders was greater ( þ 56%) than that measured in nondefeated intruders (Figure 8) . Moreover, when defeated intruders were moved to the protective cage inside the resident home cage, a sharp increase in CCKLM extracellular levels was observed in the corresponding (eighth) microdialysate fraction (3.4770.15 pg per fraction, þ 210%, P < 0.001, n = 5), Subsequently, CCKLM levels returned to basal values and remained stable until the end of the experiment.
Chronic treatment with imipramine completely prevented the increase of spontaneous cortical CCKLM release in defeated animals while it did not affect the peptide release in nondefeated rats (Figure 8 ). Thus, in imipramine-defeated as well as nondefeated rats, CCKLM release did not differ from that measured in saline-nondefeated rats (Figure 8 ). In defeated intruders treated with imipramine, moving to the resident home cage induced an increase of cortical CCKLM release (1.4670.09 pg per fraction, þ 130%, P < 0.05, n = 8). In contrast, no such effect was noted in nondefeated rats, whether they were treated with imipramine or saline. Two-way ANOVA for repeated measures revealed significant main 
Discussion
The present study investigated in rats the consequences of prolonged repeated social defeat on biochemical, physiological and behavioral parameters. That a chronic treatment with imipramine, a tricyclic antidepressant, could prevent the changes induced by the prolonged social-defeat procedure in all the measured parameters does support the idea that this paradigm causes a depression-like syndrome in rats. The marked activation of cortical CCKergic systems observed in defeated animals and the prevention of social defeat-evoked behavioral and physiological alterations by chronic CCK2 receptor blockade strongly suggest that CCKergic neurotransmission mediates-at least in part-depression-like symptoms in these animals.
The central question of our study was to assess the validity of prolonged social-defeat procedure as a model of depression in rats. Most relevant studies have implicated chronic stress as a major factor in the onset of depression. The chronic character of stressors may result in various forms of stress pathology. However, chronic stress is not a well-defined concept. Using a series of intermittent daily changing stressors rather than the continuous presence of a stressor has limited relevance to mimic the etiology of depression. 43 Moreover, to have a really heuristic value, stressors must mimic the environmental challenges that an animal may meet in its everyday life in natural environment with respect to the type, severity and frequency of the stressors. 43, 44 In this context, loss of environmental control (in a social setting, this might mean a loss of social control, that is, social defeat 43 ) in particular is a major factor in inducing stress pathology. 44 For these reasons, using an expanded (over 20 days 13 ) social stressor repeated over 4 weeks in rats provides a realistic simulation of the etiology of depression.
The face validity of the model of prolonged social defeat has been assessed. In animals, the subjective dimensions (evaluated through speaking in humans) cannot be estimated. Thus, only objective symptoms can be measured, knowing that they correspond to a minor point allowing only confirmation of the depression diagnostic according to Diagnostic and Statistical Manual of Mental Disorders, fourth edition. 45 Prolonged social-defeat procedure resulted in profound long-term changes of behavioral and biological parameters in subordinate rats. In particular, as expected, the experimental protocol produced a hyperactivity of HPA axis, as shown by the increases in serum corticosterone levels and adrenal gland weight, and decreases of body weight and sweet water consumption. A dysregulation of HPA axis is a welldocumented finding in major depression. 46, 47 Another behavioral change that may be regarded as a relevant index of the depression-like symptom of helplessness is the prolonged immobility in the FST, as previously described. 16 The decrease of sweet water consumption in defeated animals is interpreted as an index of anhedonia, which is considered as a core symptom for the diagnosis of major depression. 48 Numerous studies reported that repeatedly defeated animals gained less weight than undefeated ones. 32, 44, 49, 50 In the present study, this effect could not be due to the decrease in sweet water consumption because no differences in body weight were noted between nondefeated animals drinking only plain water and those drinking sweet water. Indeed, previous studies showed that no clear relationship exists between changes in sucrose intake and changes in body weight. 51 Rather, the decreased body weight in saline-defeated rats must probably result from the reduction of food consumption compared with salinenondefeated rats. On the other hand, we showed that the prolonged social-defeat procedure induced a decrease of both hippocampal volume and hippocampal cell proliferation. The reduction of hippocampal volume in patients with major depression 52, 53 and in animals subjected to chronic psychosocial stress 54 could be attributed to neuron death, atrophy of neuronal processes, loss of glia and/or decreased neurogenesis. 55 Numerous studies have shown that psychological stress, inescapable stress, exposure to predator odor stress, repeated restraint stress or repeated social defeat do decrease cell proliferation in hippocampus of nonhuman primates, 56,57 rats 54, [58] [59] [60] and mice. 37 In agreement with previous reports, 36, 61 we also showed that the majority of the new cells differentiated into mature neurons. Accordingly, a body of converging arguments strongly suggests that the prolonged social-defeat procedure herein described can be considered as a suitable model of depression. One additional criterion is the pharmacological validation and, therefore, we documented the effects of antidepressant treatment.
We chose to give imipramine, a clinically effective tricyclic antidepressant, through an implanted minipump because (1) a relatively constant level of imipramine can be delivered to the animals throughout the day and (2) the procedure is not stressful. In order to better approximate clinical conditions, Figure 8 Cortical cholecystokinin-like material (CCKLM) release in defeated and nondefeated rats-effects of imipramine treatment. CCKLM contents were measured in 30-min microdialysis fractions (90 ml) collected at the level of the frontal cortex in freely moving rats. Fraction 1 corresponded to the first fraction collected after a 90-min washout period following microdialysis probe insertion. Two minutes before the beginning of the collection of the eighth fraction, intruders (either defeated or nondefeated) were subjected to the period I of the social-defeat procedure. CCKLM levels (in pg per fraction) were analyzed using ANOVA followed by appropriate pairwise comparisons (Bonferroni test). Data are the means7s.e.m. of CCKLM contents in collected fractions expressed as pg per fraction (**P < 0.01, ***P < 0.001, ****P < 0.0001 vs saline-nondefeated intruders; w P < 0.05, www P < 0.001 compared to basal values (1.6670.06 pg per fraction for saline-defeated intruders and 1.0970.03 pg per fraction for imipramine-defeated intruders)). chronic treatment with imipramine was started at the end of the fourth conditioning session, when rats exhibited patent depression-like symptoms. Moreover, the time course for the drug application was consistent with that for the therapeutic action of antidepressants in patients. 62 The predictive validity of the prolonged social defeat model of human depression is suggested by the clear-cut actions of imipramine on the different symptoms. Indeed, only the body weight loss was not prevented by chronic treatment with imipramine, in line with previous studies. 50, 63 Thus, after a transient decrease of sweet water consumption in imipramine-treated defeated rats during the first week of treatment, sucrose intake in these animals increased up to that observed in nondefeated rats during the last week of treatment, as expected from the time course of action of chronic antidepressant treatment. Moreover, chronic imipramine antidepressant treatment normalized immobility time of defeated rats in the FST. These results confirmed those of Rygula et al. 16 and Berton et al.
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showing that antidepressant treatment reversed the prolonged immobility of defeated animals in the FST and their loss of sugar preference.
As expected from a validated model of depression, the activation of HPA axis induced by the prolonged social-defeat procedure was also found to be suppressed by chronic imipramine treatment. Indeed, clinically effective therapy with antidepressant drugs has been repeatedly reported to normalize the HPA axis activity. 46, 47 Finally, the decreases of hippocampal cell proliferation and hippocampal volume in defeated rats were prevented by imipramine treatment, in line with previous studies showing that chronic administration of antidepressants counteracted the downregulation of cell proliferation and the reduction of hippocampus volume resulting from intruder stress or inescapable stress. 54, 59 In addition, on its own, chronic imipramine treatment did not increase hippocampal cell proliferation in nondefeated rats, in agreement with the data reported by Czeh et al. 54 Since the social defeat-evoked changes in all the measured parameters were prevented by the chronic treatment with imipramine and since the prolonged social stressor lasted for 4 weeks, 13, 18 it can be legitimately concluded that our experimental procedure does indeed mimic, in rats, several depressive symptoms in humans.
In the present study, we focused our investigation on CCKergic systems in order to document a possible causal link between the appearance of depression-like symptoms and modifications in CCK neurotransmission (see 'Introduction'). For this purpose, we performed microdialysis experiments to estimate the cortical release of the peptide. Indeed, we have previously shown that extracellular CCK levels reflect neuronal CCK release, which can be triggered in a calcium-dependent manner by potassium-induced depolarization. 23 Here, we showed that the spontaneous CCKLM release was significantly increased in the frontal cortex of saline-defeated rats compared to saline-nondefeated rats, thus strongly suggesting that cortical CCKergic neurotransmission was tonically stimulated by the social-defeat procedure. However, such an increase of spontaneous CCKLM release was not observed when social defeat was applied for only 4 days, 11, 32 indicating that a prolonged exposure to this stressful situation is needed to sensitize the cortical CCKergic systems. Indeed, as expected from such change, cortical CCK release was markedly enhanced during the stressful 30-min of period I 11 to which defeated rats were exposed after the 4-week conditioning sessions. Interestingly, chronic treatment with imipramine completely prevented the increase of basal cortical CCKLM release and markedly reduced the period I-evoked peptide release, indicating that activation of cortical CCKergic systems was closely related to the depression-like state of the animals. In support of this hypothesis, we observed that chronic treatment with the selective CCK2 receptor antagonist, CI-988, prevented all of the social defeat-induced behavioral, neurobiological and biological changes (except for the increase in adrenal gland weight and the decrease in body weight). In addition, CI-988 was found to exert no anorectic effect in line with convergent data showing that food intake is mediated by CCK1, but not CCK2 receptors. 31, 64 To our knowledge, only two studies have reported alleviating effects of subchronic CI-988 treatment (7-14 days), but in anxiety models. 40, 65 Therefore, our study is the first showing antidepressant-like effects of this CCK2 receptor antagonist under long-term treatment conditions. Furthermore, the data obtained with CI-988 strongly support the idea that activated CCKergic neurotransmission is causally related to the emergence of depression-like symptoms in rats repeatedly exposed to social defeat. Thus, all these data strongly suggest that CCKergic systems may be a relevant target for antidepressant therapy.
